Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Am J Vet Res ; 80(10): 912-922, 2019 Oct.
Article in English | MEDLINE | ID: mdl-31556714

ABSTRACT

OBJECTIVE: To investigate the cardiovascular and sedation reversal effects of IM administration of atipamezole (AA) in dogs treated with medetomidine hydrochloride (MED) or MED and vatinoxan (MK-467). ANIMALS: 8 purpose-bred, 2-year-old Beagles. PROCEDURES: A randomized, blinded, crossover study was performed in which each dog received 2 IM treatments at a ≥ 2-week interval as follows: injection of MED (20 µg/kg) or MED mixed with 400 µg of vatinoxan/kg (MEDVAT) 30 minutes before AA (100 µg/kg). Sedation score, heart rate, mean arterial and central venous blood pressures, and cardiac output were recorded before and at various time points (up to 90 minutes) after AA. Cardiac and systemic vascular resistance indices were calculated. Venous blood samples were collected at intervals until 210 minutes after AA for drug concentration analysis. RESULTS: Heart rate following MED administration was lower, compared with findings after MEDVAT administration, prior to and at ≥ 10 minutes after AA. Mean arterial blood pressure was lower with MEDVAT than with MED at 5 minutes after AA, when its nadir was detected. Overall, cardiac index was higher and systemic vascular resistance index lower, indicating better cardiovascular function, in MEDVAT-atipamezole-treated dogs. Plasma dexmedetomidine concentrations were lower and recoveries from sedation were faster and more complete after MEDVAT treatment with AA than after MED treatment with AA. CONCLUSIONS AND CLINICAL RELEVANCE: Atipamezole failed to restore heart rate and cardiac index in medetomidine-sedated dogs, and relapses into sedation were observed. Coadministration of vatinoxan with MED helped to maintain hemodynamic function and hastened the recovery from sedation after AA in dogs.


Subject(s)
Adrenergic alpha-2 Receptor Antagonists/pharmacology , Cardiovascular System/drug effects , Dogs , Hypnotics and Sedatives/pharmacology , Imidazoles/pharmacology , Medetomidine/pharmacology , Quinolizines/pharmacology , Anesthesia/veterinary , Animals , Cardiac Output/drug effects , Cross-Over Studies , Dexmedetomidine/pharmacology , Heart Rate/drug effects , Hemodynamics/drug effects , Injections, Intramuscular/veterinary , Male , Medetomidine/administration & dosage , Medetomidine/antagonists & inhibitors , Quinolizines/antagonists & inhibitors , Random Allocation , Single-Blind Method
SELECTION OF CITATIONS
SEARCH DETAIL
...